Showing results (1331-1340 of 1,559) with videos related to

Sort By:
Pageof 156
Journal of Medical Genetics|August 1, 2018
Mutations in IRS4 are associated with central hypothyroidismCharlotte A Heinen, Emmely M de Vries, Mariëlle Alders, et al.
Endocrine Connections|November 5, 2017
Increased circulating interleukin-8 in patients with resistance to thyroid hormone receptor αAnne H van der Spek, Olga V Surovtseva, Saskia Aan, et al.
The Journal of Infectious Diseases|February 11, 2000
Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United StatesP S Sullivan, A N Do, D Ellenberger, et al.
Nature Communications|July 17, 2020
Co-option of Plasmodium falciparum PP1 for egress from host erythrocytesAditya S Paul, Alexandra Miliu, Joao A Paulo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 23, 2019
A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologiesAlberto J Espay, Jeffrey M Hausdorff, Álvaro Sánchez-Ferro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Interactions between menopause and high-fat diet on cognition and pathology in a mouse model of Alzheimer's diseaseCharly Abi-Ghanem, Richard D Kelly, Emily A Groom, et al.
Blood|April 8, 2026
A Novel G13-RAPGEF2-RAP1 Signaling Pathway Critical for Platelet AdhesionDavid S Paul, David J Rocco, Emily G Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2013
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progressionYasuhiro Yoshimatsu, Yulia G Lee, Yuichi Akatsu, et al.
Neurology|January 2, 2015
Exercise for falls prevention in Parkinson disease: a randomized controlled trialColleen G Canning, Catherine Sherrington, Stephen R Lord, et al.
The Journal of Clinical Investigation|November 6, 2019
Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia modelsSantiago Ruiz, Haitian Zhao, Pallavi Chandakkar, et al.
Pageof 156